UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 185

Sortiert nach

Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma

Cancer cell, 2015-03, Vol.27 (3), p.342-353

2015

Link zum Volltext

Verfügbarkeit prüfen

Open-Label, Exploratory Phase II Trial of Oral Itraconazole for the Treatment of Basal Cell Carcinoma

Journal of clinical oncology, 2014-03, Vol.32 (8), p.745-751

2014

Link zum Volltext

Verfügbarkeit prüfen

Distinguishing malignant from benign microscopic skin lesions using desorption electrospray ionization mass spectrometry imaging

Proceedings of the National Academy of Sciences - PNAS, 2018-06, Vol.115 (25), p.6347-6352

2018

Link zum Volltext

Verfügbarkeit prüfen

Serlopitant for the treatment of chronic pruritus: Results of a randomized, multicenter, placebo-controlled phase 2 clinical trial

Journal of the American Academy of Dermatology, 2018-05, Vol.78 (5), p.882-891.e10

2018

Link zum Volltext

Verfügbarkeit prüfen

Itraconazole and Arsenic Trioxide Inhibit Hedgehog Pathway Activation and Tumor Growth Associated with Acquired Resistance to Smoothened Antagonists

Cancer cell, 2013-01, Vol.23 (1), p.23-34

2013

Link zum Volltext

Verfügbarkeit prüfen

Update on metastatic basal cell carcinoma: a summary of published cases from 1981 through 2011

JAMA dermatology (Chicago, Ill.), 2013-05, Vol.149 (5), p.615

2013

Link zum Volltext

Verfügbarkeit prüfen

Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma

Cancer cell, 2015-03, Vol.27 (3), p.327-341

2015

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma

Nature communications, 2016-07, Vol.7 (1), p.12048-12048, Article 12048

2016

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

The lancet oncology, 2016-12, Vol.17 (12), p.1720-1731

2016

Link zum Volltext

Verfügbarkeit prüfen

Noncanonical hedgehog pathway activation through SRF-MKL1 promotes drug resistance in basal cell carcinomas

Nature medicine, 2018-03, Vol.24 (3), p.271-281

2018

Link zum Volltext

Verfügbarkeit prüfen

Gorlin Syndrome: Assessing Genotype-Phenotype Correlations and Analysis of Early Clinical Characteristics as Risk Factors for Disease Severity

Journal of clinical oncology, 2022-07, Vol.40 (19), p.JCO2102385-2127

2022

Link zum Volltext

Verfügbarkeit prüfen

Statin use and all-cancer survival: prospective results from the Women's Health Initiative

British journal of cancer, 2016-06, Vol.115 (1), p.129-135

2016

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma

Nature communications, 2016-08, Vol.7 (1), p.12510-12510, Article 12510

2016

Link zum Volltext

Verfügbarkeit prüfen

Neuronal delivery of Hedgehog directs spatial patterning of taste organ regeneration

Proceedings of the National Academy of Sciences - PNAS, 2018-01, Vol.115 (2), p.E200-E209

2018

Link zum Volltext

Verfügbarkeit prüfen

LY6D marks pre-existing resistant basosquamous tumor subpopulations

Nature communications, 2022-12, Vol.13 (1), p.7520-7520

2022

Link zum Volltext

Verfügbarkeit prüfen

Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa

Orphanet journal of rare diseases, 2022-10, Vol.17 (1), p.1-377, Article 377

2022

Link zum Volltext

Verfügbarkeit prüfen

Lack of efficacy with 1064-nm neodymium:yttrium-aluminum-garnet laser for the treatment of onychomycosis: A randomized, controlled trial

Journal of the American Academy of Dermatology, 2014-05, Vol.70 (5), p.911-917

2014

Link zum Volltext

Verfügbarkeit prüfen

Calcium Plus Vitamin D Supplementation and the Risk of Nonmelanoma and Melanoma Skin Cancer: Post Hoc Analyses of the Women's Health Initiative Randomized Controlled Trial

Journal of clinical oncology, 2011-08, Vol.29 (22), p.3078-3084

2011

Link zum Volltext

Verfügbarkeit prüfen

Classification of basal cell carcinoma in human skin using machine learning and quantitative features captured by polarization sensitive optical coherence tomography

Biomedical optics express, 2016-09, Vol.7 (9), p.3721-3735

2016

Link zum Volltext

Verfügbarkeit prüfen

Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study

Orphanet journal of rare diseases, 2021-09, Vol.16 (1), p.377-377, Article 377

2021

Link zum Volltext

Verfügbarkeit prüfen

Gene Therapy for Epidermolysis Bullosa

Journal of investigative dermatology, 2019-06, Vol.139 (6), p.1221-1226

2019

Link zum Volltext

Verfügbarkeit prüfen

Update to an open-label clinical trial of vismodegib as neoadjuvant before surgery for high-risk basal cell carcinoma (BCC)

Journal of the American Academy of Dermatology, 2016-07, Vol.75 (1), p.213-215

2016

Link zum Volltext

Verfügbarkeit prüfen

Different Fgfs have distinct roles in regulating neurogenesis after spinal cord injury in zebrafish

Neural development, 2018-11, Vol.13 (1), p.24-24, Article 24

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 185

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(171)
Mit Volltextzugriff
(167)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma

Open-Label, Exploratory Phase II Trial of Oral Itraconazole for the Treatment of Basal Cell Carcinoma

Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition

Distinguishing malignant from benign microscopic skin lesions using desorption electrospray ionization mass spectrometry imaging

Serlopitant for the treatment of chronic pruritus: Results of a randomized, multicenter, placebo-controlled phase 2 clinical trial

Itraconazole and Arsenic Trioxide Inhibit Hedgehog Pathway Activation and Tumor Growth Associated with Acquired Resistance to Smoothened Antagonists

Update on metastatic basal cell carcinoma: a summary of published cases from 1981 through 2011

Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma

Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma

Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Noncanonical hedgehog pathway activation through SRF-MKL1 promotes drug resistance in basal cell carcinomas

Gorlin Syndrome: Assessing Genotype-Phenotype Correlations and Analysis of Early Clinical Characteristics as Risk Factors for Disease Severity

Statin use and all-cancer survival: prospective results from the Women's Health Initiative

Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma

Neuronal delivery of Hedgehog directs spatial patterning of taste organ regeneration

LY6D marks pre-existing resistant basosquamous tumor subpopulations

Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa

Lack of efficacy with 1064-nm neodymium:yttrium-aluminum-garnet laser for the treatment of onychomycosis: A randomized, controlled trial

Calcium Plus Vitamin D Supplementation and the Risk of Nonmelanoma and Melanoma Skin Cancer: Post Hoc Analyses of the Women's Health Initiative Randomized Controlled Trial

Classification of basal cell carcinoma in human skin using machine learning and quantitative features captured by polarization sensitive optical coherence tomography

Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study

Gene Therapy for Epidermolysis Bullosa

Update to an open-label clinical trial of vismodegib as neoadjuvant before surgery for high-risk basal cell carcinoma (BCC)

Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa

Different Fgfs have distinct roles in regulating neurogenesis after spinal cord injury in zebrafish

Suchergebnisse filtern